Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · IEX Real-Time Price · USD
23.08
-0.14 (-0.60%)
At close: Jul 19, 2024, 4:00 PM
23.10
+0.02 (0.09%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Syndax Pharmaceuticals Market Cap
Syndax Pharmaceuticals has a market cap or net worth of $1.96 billion as of July 22, 2024. Its market cap has increased by 38.69% in one year.
Market Cap
1.96B
Enterprise Value
1.52B
1-Year Change
38.69%
Ranking
Category
Stock Price
$23.08
Market Cap Chart
Since March 3, 2016, Syndax Pharmaceuticals's market cap has increased from $208.60M to $1.96B, an increase of 840.32%. That is a compound annual growth rate of 30.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.96B | 30.34% |
| Dec 29, 2023 | 1.50B | -1.81% |
| Dec 30, 2022 | 1.53B | 41.76% |
| Dec 31, 2021 | 1.08B | 18.96% |
| Dec 31, 2020 | 908.90M | 281.41% |
| Dec 31, 2019 | 238.30M | 115.66% |
| Dec 31, 2018 | 110.50M | -48.29% |
| Dec 29, 2017 | 213.70M | 63.88% |
| Dec 30, 2016 | 130.40M | -37.49% |
| Mar 3, 2016 | 208.60M | - |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 10x Genomics | 2.00B |
| Edgewise Therapeutics | 1.99B |
| Immunocore Holdings | 1.99B |
| Recursion Pharmaceuticals | 1.99B |
| NovoCure | 1.98B |
| Arvinas | 1.95B |
| Novavax | 1.94B |
| Amphastar Pharmaceuticals | 1.94B |